| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/07/2005 | WO2004097017A3 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
| 04/07/2005 | US20050076398 Lysine starve rodent model for identifying modulators for treartment and prevention of gastrointestinal disorders |
| 04/07/2005 | US20050076397 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 04/07/2005 | US20050074498 Perforated microstructure; flowability, dispersibility; stable aerosols; respiratory inhalants |
| 04/07/2005 | US20050074457 Simplified, high throughput screening for identification of heat shock protein 90 ligands selective for high affinity form |
| 04/07/2005 | US20050074455 Treatment of neovascular opthalmic disease |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | US20050074412 especially for endoscopic surgery, comprising a rinsing fluid and nitrous oxide added as a marker in an amount detectable in the expired breath from a mammal, especially man, that is subjected to the surgery. |
| 04/07/2005 | US20050074411 Synthesis of an magnetic resonance imaging (MRI) agent by reacting a peptide with p-xylylenediamine and covalently attaching a linker moiety, reacting with a precursor chelate moiety having protected carboxy groups, deprotecting, and chelating with a paramagnetic metal ion |
| 04/07/2005 | US20050074409 Complexes have critical micelle formation concentration, hydrodynamic micelle diameter, and proton relaxivity in plasma contrast media in MR imaging |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | US20050074407 polyvinylpyrrolidone and polyvinyl alcohol water based gel; alkylene glycols, polyalkylene glycols added to adjust texture and drying characteristics |
| 04/07/2005 | US20050074406 Ultrasound coating for enhancing visualization of medical device in ultrasound images |
| 04/07/2005 | US20050074405 Contrast media for use in medical and diagnostic procedures and methods of using the same |
| 04/07/2005 | US20050074404 Methods for avoiding renal injury |
| 04/07/2005 | US20050074403 A mixture of polynucleotides, polylysine conjugated to transferrin or to diethylenetriaminepentaacetic acid, and chelate compound of gadolinium; contrast agents, tissue-targeted therapy for magnetic resonance imaging |
| 04/07/2005 | US20050074400 targets brain tumor protein targets which allow for the selective inhibition of cell function or selective marking for visualization with therapeutic or visualizing compositions which have a specific affinity for these protein targets |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539924A1 Conjugates for photodynamic therapy |
| 04/07/2005 | CA2539914A1 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | CA2538101A1 A method of evaluating organ function |
| 04/07/2005 | CA2531894A1 Inherently radiopaque polymeric products for embolotherapy |
| 04/06/2005 | EP1520588A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/06/2005 | EP1520032A2 Lung cancer therapeutics and diagnostics |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519757A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 04/06/2005 | EP1519756A2 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi |
| 04/06/2005 | EP1519735A2 Assays and implements for determining and modulating hsp90 binding activity |
| 04/06/2005 | EP1519683A2 Solid hydrogel coupling for ultrasound imaging and therapy |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/05/2005 | US6875864 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 04/05/2005 | US6875444 Radiation transparent strip with adhesive surface; measuring efficiency of antiaging cosmetics |
| 04/05/2005 | US6875421 Contacting a preferred area with a dye that is capable of binding or conjugating to chitin and emitting fluorescence upon exposure to light for detecting chitin containing organisms on such area of a person or an animal |
| 04/05/2005 | US6875420 Method of ultrasound imaging |
| 04/05/2005 | US6875419 Paramagnetic metal ion-based macrocyclic magnetization transfer contrast agents and method of use |
| 04/05/2005 | US6875418 Method of early detection of Duchenne muscular dystrophy and other neuromuscular disease |
| 04/05/2005 | CA2395325C Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques |
| 04/05/2005 | CA2145509C 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
| 03/31/2005 | WO2005027954A2 Sincalide formulations |
| 03/31/2005 | WO2005027828A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 03/31/2005 | WO2005027827A2 Host defense factor x (hdfx) |
| 03/31/2005 | WO2005004883A3 Compound testing method |
| 03/31/2005 | WO2005004592A8 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 03/31/2005 | WO2004113270A3 Propionic acid derivatives useful in the treatment of lipid disorders |
| 03/31/2005 | WO2004064742A3 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 03/31/2005 | US20050071892 Techniques and applications of establishment of SARS-CoV primate model |
| 03/31/2005 | US20050070473 administering parathyroid hormone; antiapoptotic agents; bone disorders |
| 03/31/2005 | US20050070470 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/31/2005 | US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference |
| 03/31/2005 | US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/31/2005 | US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 03/31/2005 | US20050069498 Method for identifying metabotropic glutamate receptor agonists and potentiators |
| 03/31/2005 | US20050069496 Using sensitive stain; insects, fungi, plants, nematodes: calibrating efficiency |
| 03/31/2005 | US20050069494 Polypeptide; magnetic resonance imaging; diagnosis of cancer, osteoarthritis, infections, oral disease, rheumatic diseaeses, antiarthritic agents , cardiovascular disorders |
| 03/31/2005 | US20050069493 Administering a cobalamin linked with a diamino compound to a chelating group of a detectable metal, such as a radionuclide or paramagnetic metal ion |
| 03/31/2005 | US20050069491 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression |
| 03/31/2005 | CA2540155A1 Excretable reporter systems |
| 03/31/2005 | CA2532831A1 Host defense factor x (hdfx) |
| 03/30/2005 | EP1518560A1 Use of a gas for the manufacture of a diagnosing agent for diagnosing coronary perfusion |
| 03/30/2005 | EP1518559A1 Use of a gas for the manufacture of a monitoring agent for diagnosing passage through the intestinal tract or exocrine function of the pancreas |
| 03/30/2005 | EP1337264A4 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 03/30/2005 | EP1282448B1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit |
| 03/30/2005 | EP1250093B1 Method for preventing fluorescence quenching |
| 03/30/2005 | EP1250092B1 Method for preventing fluorescence quenching |
| 03/30/2005 | EP0791056B1 Lipid-cleavage enzyme complex |
| 03/30/2005 | EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof |
| 03/30/2005 | CN1194763C Novel lipid supersonic contrast medium and preparation method thereof |
| 03/30/2005 | CN1194670C Methods and compositions for detection and diagnosis of in fectious diseases |
| 03/30/2005 | CN1194650C All-digestive tract microcapsule non-invasive introduced diagnostic and examination system |
| 03/29/2005 | US6872516 Methods of producing carbon-13 labeled biomass |
| 03/29/2005 | US6872380 Process for preparation of MR contrast agents |
| 03/29/2005 | US6872180 Device and process for quantifying bodies by means of ultrasound |
| 03/24/2005 | WO2005026195A1 Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive aspergillosis |
| 03/24/2005 | WO2005025528A1 Dye composition and method for detection of demineralized lesions in teeth |
| 03/24/2005 | WO2005025518A2 Inhibition of inward sodium currents in cancer |
| 03/24/2005 | WO2005025513A2 Guanidinium derivatives for improved cellular transport |
| 03/24/2005 | WO2005025511A2 Potassium channel mediated delivery of agents through the blood-brain barrier |
| 03/24/2005 | WO2005025508A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 03/24/2005 | WO2005025417A1 Method for analyzing airway disorders |
| 03/24/2005 | WO2005011612A3 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 03/24/2005 | WO2004112840A3 Peptide conjugate for magnetic resonance imaging |
| 03/24/2005 | WO2004108747A3 Lectin conjugates |
| 03/24/2005 | WO2004091397A8 Method of determining state variables and changes in state variables |
| 03/24/2005 | WO2004084839A3 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 03/24/2005 | WO2004064869A3 Amyloid-binding, metal-chelating agents |
| 03/24/2005 | WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 03/24/2005 | WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity |
| 03/24/2005 | WO2004025270A3 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/24/2005 | US20050065434 Polymeric marker with high radiopacity for use in medical devices |
| 03/24/2005 | US20050065430 Methods of cardiothoracic imaging - (MET-30) |
| 03/24/2005 | US20050064388 Methods and compositions for treating atheroma, tumors and other neoplastic tissue |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063913 Novel metaxalone compositions |
| 03/24/2005 | US20050063908 Comprises ultrasound detectable body including boundaries having high contrast in acoustical impedance when placed in tissue, for reflection of ultrasound during imaging |
| 03/24/2005 | US20050063904 Method for continuous visualization of a blood clot or plaque in body lumen |
| 03/24/2005 | CA2540118A1 Dye composition and method for detection of demineralized lesions in teeth |
| 03/24/2005 | CA2538754A1 Inhibition of inward sodium currents in cancer |
| 03/24/2005 | CA2538395A1 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 03/24/2005 | CA2538039A1 Method for analyzing airway disorders |